Editorial: Beyond
                    DNA
                    Suppression:
                    HBV RNA
                    as a Predictor of Hepatocarcinogenesis

Toshifumi Tada

doi:10.1111/apt.70497

journal article Dec 10, 2025

Editorial: Beyond DNA Suppression: HBV RNA as a Predictor of Hepatocarcinogenesis

Toshifumi Tada

Alimentary Pharmacology & Therapeutics Vol. 63 No. 8 pp. 1169-1170 · Wiley

View at Publisher Save 10.1111/apt.70497

Topics

No keywords indexed for this article. Browse by subject →

References

10

[1]

Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression

Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda et al.

Alimentary Pharmacology & Therapeutics 10.1111/apt.70483

[2]

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al.

Hepatology 10.1002/hep.26180

[3]

10.1007/s00535‐025‐02211‐5

[4]

Begré L. "Circulating HBV RNA and Hepatitis B Core–Related Antigen Trajectories in Persons With HIV/HBV Coinfection and Hepatitis B Surface Antigen Loss During Tenofovir Therapy" Journal of Infectious Diseases (2024)

[5]

10.1002/hep.31026

[6]

10.1016/j.jhep.2016.05.029

[7]

10.1002/hep.30082

[8]

10.3350/cmh.2021.0012

[9]

10.1016/j.jhep.2016.03.013

[10]

10.1002/hep4.1819

Metrics

0

Citations

10

References

Details

Published: Dec 10, 2025
Vol/Issue: 63(8)
Pages: 1169-1170
License: View

Authors

T

Toshifumi Tada

Division of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Hyogo Japan

Cite This Article

Toshifumi Tada (2025). Editorial: Beyond DNA Suppression: HBV RNA as a Predictor of Hepatocarcinogenesis. Alimentary Pharmacology & Therapeutics, 63(8), 1169-1170. https://doi.org/10.1111/apt.70497

Editorial: Beyond DNA Suppression: HBV RNA as a Predictor of Hepatocarcinogenesis

You May Also Like